Ukko

ReOrbit will perform in-orbit demonstration of secure space-to-space and space-to-ground data transfer for Earth Observation, part of ESA InCubed Programme

Retrieved on: 
Dienstag, April 9, 2024
Ukko, European Space Agency, Communication, ESA, IOD, Partnership, Satellite, Software, Commercial, Australian Space Agency, Architecture, Quality, Collection, EO, Communications satellite

As a continuation of the InCubed activity UKKO - Development and Demonstration of Technologies for Future Earth Observation (EO) Satellites, ReOrbit is planning an in-orbit demonstration (IOD) as an independent standalone flight opportunity.

Key Points: 
  • As a continuation of the InCubed activity UKKO - Development and Demonstration of Technologies for Future Earth Observation (EO) Satellites, ReOrbit is planning an in-orbit demonstration (IOD) as an independent standalone flight opportunity.
  • ReOrbit will perform the commissioning and validation of end-to-end operations including imaging, onboard data processing and data transfer to customer location.
  • "We are thrilled to have partnered with ESA InCubed Programme, which has been instrumental to achieve our commercial and development success so far.
  • The technology ReOrbit has been developing for ESA InCubed Programme has been already confirmed to be purchased by KaleidEO, a subsidiary of SatSure Analytics India.

Ukko Appoints Pharma Industry Leader Dr. Tim Garnett to Advisory Board

Retrieved on: 
Dienstag, September 13, 2022
Pharmaceutical Research and Manufacturers of America, Food, Therapy, Policy, Prevalence, TEL, Pharmacy, Immunology, TIME, Bayer, Degenerative disease, Endocrinology, Khosla Ventures, Protein engineering, CEO, Protein, Solution, Leadership, Science, Taste, Biotechnology, R, Multimedia, AI, Eli Lilly, ContiGroup Companies, Food allergy, View, Eric Schmidt, Pharmaceutical industry, Vaccine, Ukko

TEL AVIV, Israel, Sept. 13, 2022 /PRNewswire/ -- Ukko, the biotechnology company designing new proteins to treat and manage food allergies, today announced the expansion of its advisory board with the appointment of Dr. Tim Garnett, former Chief Medical Officer of Eli Lilly. Dr. Garnett brings decades of experience, influence, and leadership in the drug development space and will lend his expertise to Ukko as it advances its food allergy therapeutic into clinical trials and commercialization.

Key Points: 
  • Ukko uses its AI-driven protein engineering platform to design measurably better and safer proteins for use in food and therapeutics.
  • "As Ukko progresses towards the clinical stage, we are thrilled to add Dr. Tim Garnett to our advisory board," said Anat Binur, co-founder and CEO of Ukko.
  • Ukko's advisory board supports the company on the policy, business strategy, science, and clinical aspects of Ukko's work.
  • Dr. Garnett joins several other advisory board members already in place .

Tromox Mino Electric Motorcycle Receives Accolades at 2022 Hana Bank Seoul E-Prix

Retrieved on: 
Mittwoch, August 31, 2022
Technology, Mino, Hana Bank, Formula, High, Samsung, FIA, ABB, Ukko, Big data, 2020–21 Formula E World Championship, Formula E, Olympic Park, Jonathan Tennyson (car designer), Aluminium, Rail transport, Electric battery

SEOUL, South Korea, Aug. 31, 2022 /PRNewswire/ -- Tromox, a rapidly emerging name in the world of electric mobility, was one of the key participants at the recently concluded 2022 Hana Bank Seoul E-Prix.

Key Points: 
  • SEOUL, South Korea, Aug. 31, 2022 /PRNewswire/ -- Tromox, a rapidly emerging name in the world of electric mobility, was one of the key participants at the recently concluded 2022 Hana Bank Seoul E-Prix.
  • As the only electric motorcycle manufacturer to take part in this Formula E event, Tromox garnered a lot of interest with its popular Mino model.
  • Mino is a mini electric bike from Tromox designed specifically for the city dwellers.
  • Tromox is also on the verge of introducing its upcoming model the Ukko that has already won the iF Design Award 2022.

Bayer Set to Drive Breakthrough Innovations in the Life Sciences

Retrieved on: 
Freitag, April 1, 2022
Other Health, Research, Pharmaceutical, Other Natural Resources, Agriculture, Natural Resources, Genetics, Science, Biotechnology, Stem Cells, Other Science, Health, Carbon, Pulmonary fibrosis, Disease, Risk, Therapy, Trust, Group, Primary health care, Climate change, Safety and Health in Agriculture Convention, 2001, Growth, Board, Ownership, Agricultural science, Ukko, Cellino, Artificial intelligence, Industry, Biology, Farmer, Seed, Chief executive officer, Cell, Acquisition, Medication, RNA interference, Ageing, Glycogen storage disease type II, Crop protection, Chemistry, List of life sciences, Drug discovery, Solution, Informatics for Consumer Health, Heart, Development, Richard Barker (life sciences and healthcare leader), Weather, Bluerock Creek, Food, Food security, Patient, Fine chemical, Agriculture, Pharmaceutical industry, Health, Pharma, Finance Secretary (India), Bayer, Agriculture

Today, Bayer held its first ever Breakthrough Innovation Forum, focusing on longer-term opportunities for health and agriculture leveraging emerging technologies.

Key Points: 
  • Today, Bayer held its first ever Breakthrough Innovation Forum, focusing on longer-term opportunities for health and agriculture leveraging emerging technologies.
  • The event followed Bayers recent short- and mid-term pipeline updates for its Pharma and Crop Science Divisions and shared further insights on Bayers ongoing progress to drive long-term breakthrough innovations in the Life Sciences.
  • We stand at the dawn of a new age of innovation in the Life Sciences, said Werner Baumann, Chairman of the Board of Management of Bayer AG.
  • The event also provided tangible examples of Bayers ongoing work to change the paradigms in Life Sciences.

Government invests in precision agriculture to enhance competitiveness and efficiency

Retrieved on: 
Mittwoch, Februar 16, 2022
Adoption, The Honourable, Government, Agriculture and Agri-Food Canada, AG, Efficiency, Farmer, Environment, Technology, Government of Canada, Population, FPT, Research, Foresite Capital, Ukko, Agriculture, Agriculture

OTTAWA, ON, Feb. 16, 2022 /CNW/ - Precision agriculture tools are helping farmers better manage their operations and become more efficient.

Key Points: 
  • OTTAWA, ON, Feb. 16, 2022 /CNW/ - Precision agriculture tools are helping farmers better manage their operations and become more efficient.
  • This investment will help advance the cutting-edge technology that modern farm operations need to enhance efficiency and yields.
  • The Government of Canada remains committed to investing in innovative precision agriculture tools as a fundamental way to help the Canadian agricultural sector grow and remain competitive.
  • We look forward to working with our partners and the government to advance data-based decision making in agriculture."